most safety data extrapolated from animal models Regulatory warning / FDA issued warning letters to compounders making BPC-157 claims in 2023-2024 Why BPC-157 Overdose Data Is So Limited The single biggest challenge in discussing BPC-157 overdose is the near-total absence of controlled human dosing studies
Pseudogene Ints6p1 regulates its cognate gene Ints6 through competitive binding of Mir-17-5p in hepatocellular carcinoma
Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Clin Exp Immunol (2014) 178:23644
Both peptides show significant potential in enhancing wound healing, promoting collagen synthesis, and reducing inflammation in experimental models
Counterion testing Testing should examine whether acetate, trifluoroacetate or another counterion is present alongside the claimed arginate form
